| Literature DB >> 20363625 |
Stéphane Raeppel1, Frédéric Gaudette, Michael Mannion, Stephen Claridge, Oscar Saavedra, Ljubomir Isakovic, Robert Déziel, Normand Beaulieu, Carole Beaulieu, Isabelle Dupont, Hannah Nguyen, James Wang, A Robert Macleod, Christiane Maroun, Jeffrey M Besterman, Arkadii Vaisburg.
Abstract
A novel series of N-(3-fluoro-4-(2-substituted-thieno[3,2-b]pyridin-7-yloxy)phenyl)-1-phenyl-5-(trifluoromethyl)-1H-pyrazole-4-carboxamides targeting RON receptor tyrosine kinase was designed and synthesized. SAR study of the series allowed us to identify compounds possessing either inhibitory activity of RON kinase enzyme in the low nanomolar range with low residual activity against the closely related c-Met or potent dual inhibitory activity against RON and c-Met, with no significant activity against VEGFR2 in both cases. 2010 Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20363625 DOI: 10.1016/j.bmcl.2010.03.073
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823